Literature DB >> 9623940

Effectiveness of chemoprophylaxis and other determinants of malaria in travellers to Kenya.

N Muehlberger1, T Jelinek, U Schlipkoeter, F von Sonnenburg, H D Nothdurft.   

Abstract

OBJECTIVE: To investigate the effectiveness of chemoprophylaxis and the determinants of malaria importation from Kenya.
METHOD: In a population-based case-control study, 51 travellers from Bavaria diagnosed with falciparum malaria imported from Kenya (cases) and a sample of 383 healthy Bavarian travellers returning from Kenya (controls) were interviewed. Data were analysed by multiple logistic regression.
RESULTS: Mefloquine (OR = 0.055; 95% CI 0.019-0.16) and chloroquine combined with proguanil (OR = 0.128; 95% CI 0.039-0.419) were highly protective against P. falciparum malaria, whereas other drugs were ineffective (OR = 1.225; 95% CI 0.536-2.803). Ineffective prophylaxis (10.4%) and non-prophylaxis (11.2%) were the main reasons for malaria importation. Travelling alone or with friends, male sex, and travel duration over 4 weeks could be identified as additional risk factors. The main reason for inadequate chemoprophylaxis was inappropriate medical advice (87.5%). Prophylaxis refusal occurred frequently despite correct advice (58.1%). Diagnosis was often delayed unnecessarily (27.5%).
CONCLUSION: Malaria importation from Kenya could be reduced substantially (34%) by eliminating inappropriate medical advice.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9623940     DOI: 10.1046/j.1365-3156.1998.00235.x

Source DB:  PubMed          Journal:  Trop Med Int Health        ISSN: 1360-2276            Impact factor:   2.622


  8 in total

Review 1.  Antimalarial chemoprophylaxis in infants and children.

Authors:  M H Kramer; H O Lobel
Journal:  Paediatr Drugs       Date:  2001       Impact factor: 3.022

Review 2.  Modern malaria chemoprophylaxis.

Authors:  G Dennis Shanks; Michael D Edstein
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Cost-effectiveness analysis of malaria chemoprophylaxis for travellers to West-Africa.

Authors:  Lukas L Widmer; Patricia R Blank; Koen Van Herck; Christoph Hatz; Patricia Schlagenhauf
Journal:  BMC Infect Dis       Date:  2010-09-22       Impact factor: 3.090

4.  Economics of malaria prevention in US travelers to West Africa.

Authors:  Kenji Adachi; Margaret S Coleman; Nomana Khan; Emily S Jentes; Paul Arguin; Sowmya R Rao; Regina C LaRocque; Mark J Sotir; Gary Brunette; Edward T Ryan; Martin I Meltzer
Journal:  Clin Infect Dis       Date:  2013-09-06       Impact factor: 9.079

5.  Human mobility and factors associated with malaria importation in Lusaka district, Zambia: a descriptive cross sectional study.

Authors:  Miriam Lowa; Lungowe Sitali; Mwiche Siame; Patrick Musonda
Journal:  Malar J       Date:  2018-11-03       Impact factor: 2.979

6.  Determinants of Compliance of Travelers with Vaccination and Malaria Prophylaxis at a Travel Clinic.

Authors:  Hea Yoon Kwon; HyeJin Lee; Jae Hyoung Im; Shin Goo Park; Yeon Ji Lee; Ji Hyeon Baek; Jin Soo Lee
Journal:  J Korean Med Sci       Date:  2019-08-26       Impact factor: 2.153

7.  Travel-related health problems of Hong Kong residents: Assessing the need for travel medicine services.

Authors:  Abu Saleh M Abdullah; Davidson H Hamer
Journal:  Travel Med Infect Dis       Date:  2006-02-17       Impact factor: 6.211

8.  Malaria risk in travelers.

Authors:  Helena Hervius Askling; Jenny Nilsson; Anders Tegnell; Ragnhild Janzon; Karl Ekdahl
Journal:  Emerg Infect Dis       Date:  2005-03       Impact factor: 6.883

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.